Soon in Israel: a simple injection for stroke. Helps in 5 seconds

Israel is expected to approve a new stroke drug, Tenecteplase (TNK), administered as a single injection in 5–10 seconds instead of a one-hour drip. The drug is already approved in the US, and studies show its effectiveness and safety.

Israel is expected to see the introduction of a new drug for stroke treatment—Tenecteplase (TNK)—administered as a single injection in 5–10 seconds, unlike the current standard Alteplase (tPA), which requires a one-hour drip. The drug is already approved in the US, and registration in Israel is expected to be completed by early 2027. According to studies, TNK is not inferior to tPA in effectiveness and does not increase the risk of brain hemorrhage. The advantages of TNK are particularly notable in patients requiring cerebral catheterization: blood flow was restored before intervention in 22% of those receiving TNK, compared to 10% in the tPA group. The Israeli Stroke Association recommends preparing for the transition to TNK as a first-choice drug. The article emphasizes that time is critical in stroke cases and urges immediate ambulance calls upon suspicion of symptoms.